The aortic stent grafts market size has grown strongly in recent years. It will grow from $3.59 billion in 2025 to $3.9 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rising prevalence of abdominal and thoracic aortic aneurysms, early adoption of evar and tevar procedures, growth in vascular surgery infrastructure, increasing availability of endovascular device technologies, growing geriatric population with cardiovascular risk.
The aortic stent grafts market size is expected to see strong growth in the next few years. It will grow to $5.3 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing procedural volumes in ambulatory and outpatient surgical centers, rising demand for hybrid and advanced stent graft systems, expansion of screening programs for aortic aneurysm detection, growing investments in minimally invasive vascular therapy, increasing focus on reducing postoperative complications and hospital stay. Major trends in the forecast period include increasing preference for minimally invasive endovascular repair over open aortic surgery, growing clinical adoption of modular and customizable aortic stent graft designs, rising demand for next-generation graft materials offering greater flexibility and durability, expanding utilization of stent grafts in complex abdominal and thoracic aneurysm cases, increasing shift toward early aneurysm intervention to reduce rupture risk.
The growth of the aortic stent graft market is driven by the increasing prevalence of cardiovascular diseases. Lifestyle factors such as poor diet, lack of exercise, smoking, and rising obesity rates contribute significantly to the rise in cardiovascular disease cases. Aortic stent grafts are crucial in treating cardiovascular conditions by repairing and reinforcing weakened sections of the aorta, particularly in cases of aneurysms. According to the British Heart Foundation, coronary heart disease (CHD) was a leading cause of mortality in the UK in January 2024, responsible for approximately 68,000 deaths annually, translating to one death roughly every eight minutes. This underscores the significant impact of cardiovascular diseases on driving the growth of the aortic stent graft market.
Leading companies in the aortic stent graft market are concentrating on developing advanced products, such as stent-graft systems with enhanced stability, flexibility, and reduced risk of complications. A stent-graft system is a medical device used in endovascular procedures to address aneurysms, featuring a stent for structural support and a graft to reinforce the vessel wall. For example, in August 2024, Terumo India, a medical device company based in India, introduced the TREO Abdominal Stent-Graft System. This advanced endovascular device is designed for the treatment of infrarenal abdominal aortic aneurysms, featuring in situ limb adjustability, improved sealing, and strong fixation to ensure stability and better long-term patient outcomes.
In December 2023, Tekni-Plex Inc. strengthened its position in the healthcare sector by acquiring Seisa Medical, a US-based medical device manufacturer specializing in aortic stent grafts and valve components. This acquisition enhanced TekniPlex Healthcare's capabilities in medical materials science and process technologies, particularly in developing minimally invasive and interventional therapy devices.
Major companies operating in the aortic stent grafts market are Medtronic plc, W.L. Gore & Associates Inc, Terumo Corporation, Cook Medical Inc, Endologix Inc, Lombard Medical Ltd, MicroPort Scientific Corporation, Jotec GmbH, Braile Biomédica, Merit Medical Systems Inc, Endospan Ltd, Lifetech Scientific (Shenzhen) Co Ltd, Biomerics LLC, Bentley InnoMed GmbH, Trivascular Inc, Abbott Laboratories, Becton Dickinson and Company, Biotronik SE & Co KG, Altura Medical Inc, S&G Biotech Inc.
North America was the largest region in the aortic stent grafts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aortic stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the aortic stent grafts market by increasing import and component acquisition costs for metal stent frames, graft fabrics, delivery catheters, and precision engineering parts sourced across cross-border supply chains, which raises manufacturing and procurement costs for hospitals and ambulatory surgical centers. The impact is more pronounced in regions that depend heavily on imported EVAR and TEVAR systems, including emerging Asia-Pacific, Latin America, and parts of Europe. At the same time, tariffs are accelerating localization, supplier diversification, and near-shore manufacturing initiatives, which may support domestic device production and improve long-term supply resilience across both abdominal and thoracic stent graft product segments.
The aortic stent grafts market research report is one of a series of new reports that provides aortic stent grafts market statistics, including aortic stent grafts industry global market size, regional shares, competitors with a aortic stent grafts market share, detailed aortic stent grafts market segments, market trends and opportunities, and any further data you may need to thrive in the aortic stent grafts industry. This aortic stent grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Aortic stent grafts are medical devices designed to strengthen weakened sections of the aorta, the body's primary blood vessel. They consist of a fabric tube (graft) supported by a metal mesh (stent) and are implanted using minimally invasive procedures to address conditions such as aneurysms affecting the aorta.
Abdominal aortic stent grafts and thoracic aortic stent grafts are the two main types. Abdominal aortic stent grafts specifically target abdominal aortic aneurysms by reinforcing the weakened vessel wall to prevent potential rupture. These devices find application in various settings such as hospitals, ambulatory surgical centers, and outpatient facilities for treating both abdominal and thoracic aortic aneurysms.
The aortic stent grafts market consists of sales of tube aortic stent grafts, bifurcated aortic stent grafts, and aorto-uniiliac aortic stent grafts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The aortic stent grafts market size is expected to see strong growth in the next few years. It will grow to $5.3 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing procedural volumes in ambulatory and outpatient surgical centers, rising demand for hybrid and advanced stent graft systems, expansion of screening programs for aortic aneurysm detection, growing investments in minimally invasive vascular therapy, increasing focus on reducing postoperative complications and hospital stay. Major trends in the forecast period include increasing preference for minimally invasive endovascular repair over open aortic surgery, growing clinical adoption of modular and customizable aortic stent graft designs, rising demand for next-generation graft materials offering greater flexibility and durability, expanding utilization of stent grafts in complex abdominal and thoracic aneurysm cases, increasing shift toward early aneurysm intervention to reduce rupture risk.
The growth of the aortic stent graft market is driven by the increasing prevalence of cardiovascular diseases. Lifestyle factors such as poor diet, lack of exercise, smoking, and rising obesity rates contribute significantly to the rise in cardiovascular disease cases. Aortic stent grafts are crucial in treating cardiovascular conditions by repairing and reinforcing weakened sections of the aorta, particularly in cases of aneurysms. According to the British Heart Foundation, coronary heart disease (CHD) was a leading cause of mortality in the UK in January 2024, responsible for approximately 68,000 deaths annually, translating to one death roughly every eight minutes. This underscores the significant impact of cardiovascular diseases on driving the growth of the aortic stent graft market.
Leading companies in the aortic stent graft market are concentrating on developing advanced products, such as stent-graft systems with enhanced stability, flexibility, and reduced risk of complications. A stent-graft system is a medical device used in endovascular procedures to address aneurysms, featuring a stent for structural support and a graft to reinforce the vessel wall. For example, in August 2024, Terumo India, a medical device company based in India, introduced the TREO Abdominal Stent-Graft System. This advanced endovascular device is designed for the treatment of infrarenal abdominal aortic aneurysms, featuring in situ limb adjustability, improved sealing, and strong fixation to ensure stability and better long-term patient outcomes.
In December 2023, Tekni-Plex Inc. strengthened its position in the healthcare sector by acquiring Seisa Medical, a US-based medical device manufacturer specializing in aortic stent grafts and valve components. This acquisition enhanced TekniPlex Healthcare's capabilities in medical materials science and process technologies, particularly in developing minimally invasive and interventional therapy devices.
Major companies operating in the aortic stent grafts market are Medtronic plc, W.L. Gore & Associates Inc, Terumo Corporation, Cook Medical Inc, Endologix Inc, Lombard Medical Ltd, MicroPort Scientific Corporation, Jotec GmbH, Braile Biomédica, Merit Medical Systems Inc, Endospan Ltd, Lifetech Scientific (Shenzhen) Co Ltd, Biomerics LLC, Bentley InnoMed GmbH, Trivascular Inc, Abbott Laboratories, Becton Dickinson and Company, Biotronik SE & Co KG, Altura Medical Inc, S&G Biotech Inc.
North America was the largest region in the aortic stent grafts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aortic stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the aortic stent grafts market by increasing import and component acquisition costs for metal stent frames, graft fabrics, delivery catheters, and precision engineering parts sourced across cross-border supply chains, which raises manufacturing and procurement costs for hospitals and ambulatory surgical centers. The impact is more pronounced in regions that depend heavily on imported EVAR and TEVAR systems, including emerging Asia-Pacific, Latin America, and parts of Europe. At the same time, tariffs are accelerating localization, supplier diversification, and near-shore manufacturing initiatives, which may support domestic device production and improve long-term supply resilience across both abdominal and thoracic stent graft product segments.
The aortic stent grafts market research report is one of a series of new reports that provides aortic stent grafts market statistics, including aortic stent grafts industry global market size, regional shares, competitors with a aortic stent grafts market share, detailed aortic stent grafts market segments, market trends and opportunities, and any further data you may need to thrive in the aortic stent grafts industry. This aortic stent grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Aortic stent grafts are medical devices designed to strengthen weakened sections of the aorta, the body's primary blood vessel. They consist of a fabric tube (graft) supported by a metal mesh (stent) and are implanted using minimally invasive procedures to address conditions such as aneurysms affecting the aorta.
Abdominal aortic stent grafts and thoracic aortic stent grafts are the two main types. Abdominal aortic stent grafts specifically target abdominal aortic aneurysms by reinforcing the weakened vessel wall to prevent potential rupture. These devices find application in various settings such as hospitals, ambulatory surgical centers, and outpatient facilities for treating both abdominal and thoracic aortic aneurysms.
The aortic stent grafts market consists of sales of tube aortic stent grafts, bifurcated aortic stent grafts, and aorto-uniiliac aortic stent grafts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Aortic Stent Grafts Market Characteristics
3. Aortic Stent Grafts Market Supply Chain Analysis
4. Global Aortic Stent Grafts Market Trends and Strategies
5. Aortic Stent Grafts Market Analysis of End Use Industries
7. Global Aortic Stent Grafts Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Aortic Stent Grafts Total Addressable Market (TAM) Analysis for the Market
9. Aortic Stent Grafts Market Segmentation
10. Aortic Stent Grafts Market Regional and Country Analysis
11. Asia-Pacific Aortic Stent Grafts Market
12. China Aortic Stent Grafts Market
13. India Aortic Stent Grafts Market
14. Japan Aortic Stent Grafts Market
15. Australia Aortic Stent Grafts Market
16. Indonesia Aortic Stent Grafts Market
17. South Korea Aortic Stent Grafts Market
18. Taiwan Aortic Stent Grafts Market
19. South East Asia Aortic Stent Grafts Market
20. Western Europe Aortic Stent Grafts Market
21. UK Aortic Stent Grafts Market
22. Germany Aortic Stent Grafts Market
23. France Aortic Stent Grafts Market
24. Italy Aortic Stent Grafts Market
25. Spain Aortic Stent Grafts Market
26. Eastern Europe Aortic Stent Grafts Market
27. Russia Aortic Stent Grafts Market
28. North America Aortic Stent Grafts Market
29. USA Aortic Stent Grafts Market
30. Canada Aortic Stent Grafts Market
31. South America Aortic Stent Grafts Market
32. Brazil Aortic Stent Grafts Market
33. Middle East Aortic Stent Grafts Market
34. Africa Aortic Stent Grafts Market
36. Aortic Stent Grafts Market Competitive Landscape and Company Profiles
37. Aortic Stent Grafts Market Other Major and Innovative Companies
40. Aortic Stent Grafts Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Aortic Stent Grafts Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses aortic stent grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for aortic stent grafts? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aortic stent grafts market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Abdominal Aortic Stents Graft; Thoracic Aortic Stents Graft2) By Indication: Abdominal Aortic Aneurysms; Thoracic Aortic Aneurysms
3) By End User: Hospitals; Ambulatory Surgical Centers Or Outpatient Surgical Centers; Other End-Users
Subsegments:
1) By Abdominal Aortic Stent Graft: Endovascular Aneurysm Repair (EVAR) Stent Grafts; Aortic Aneurysm Stent Grafts2) By Thoracic Aortic Stent Graft: Thoracic Endovascular Aortic Repair (TEVAR) Stent Grafts; Hybrid Aortic Stent Grafts
Companies Mentioned: Medtronic plc; W.L. Gore & Associates Inc; Terumo Corporation; Cook Medical Inc; Endologix Inc; Lombard Medical Ltd; MicroPort Scientific Corporation; Jotec GmbH; Braile Biomédica; Merit Medical Systems Inc; Endospan Ltd; Lifetech Scientific (Shenzhen) Co Ltd; Biomerics LLC; Bentley InnoMed GmbH; Trivascular Inc; Abbott Laboratories; Becton Dickinson and Company; Biotronik SE & Co KG; Altura Medical Inc; S&G Biotech Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Aortic Stent Grafts market report include:- Medtronic plc
- W.L. Gore & Associates Inc
- Terumo Corporation
- Cook Medical Inc
- Endologix Inc
- Lombard Medical Ltd
- MicroPort Scientific Corporation
- Jotec GmbH
- Braile Biomédica
- Merit Medical Systems Inc
- Endospan Ltd
- Lifetech Scientific (Shenzhen) Co Ltd
- Biomerics LLC
- Bentley InnoMed GmbH
- Trivascular Inc
- Abbott Laboratories
- Becton Dickinson and Company
- Biotronik SE & Co KG
- Altura Medical Inc
- S&G Biotech Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.9 Billion |
| Forecasted Market Value ( USD | $ 5.3 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
